Histogen to Present at the Canaccord Genuity 41st Annual Growth Conference

July 31, 2021 sandiegobiotech News Comments Off on Histogen to Present at the Canaccord Genuity 41st Annual Growth Conference

SAN DIEGO, July 29, 2021 (GLOBE NEWSWIRE) — Histogen Inc. (NASDAQ: HSTO), a clinical-stage therapeutics company focused on developing potential first-in-class restorative therapeutics that ignite the body’s natural process to repair and maintain healthy biological function, today announced that Richard W. Pascoe, President and Chief Executive Officer of Histogen, will present at the Canaccord Genuity 41st Annual Growth Conference. The virtual presentation is scheduled for Thursday, August 12, 2021 at 2:00 p.m. Eastern Time.

Click here to view original post

Related Articles

No Picture
News

Histogen Announces Closing of $3.5 Million Private Placement

December 21, 2021 sandiegobiotech News Comments Off on Histogen Announces Closing of $3.5 Million Private Placement

SAN DIEGO, Dec. 21, 2021 (GLOBE NEWSWIRE) — Histogen Inc. (NASDAQ: HSTO), a clinical-stage company focused on developing potential first-in-class restorative therapeutics that ignite the body’s natural process to repair and maintain healthy biological function, announced today the closing of its previously announced private placement for the issuance and sale… Click here to view original post… […]

No Picture
News

Histogen to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

August 31, 2021 sandiegobiotech News Comments Off on Histogen to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

SAN DIEGO, Aug. 31, 2021 (GLOBE NEWSWIRE) — Histogen Inc. (NASDAQ: HSTO), a clinical-stage therapeutics company focused on developing potential first-in-class restorative therapeutics that ignite the body’s natural process to repair and maintain healthy biological function, today announced that Richard W. Pascoe, President and Chief Executive Officer of Histogen,… Click here to view original post… […]

No Picture
News

Histogen to Report Third Quarter 2021 Financial Results on November 10, 2021

October 27, 2021 sandiegobiotech News Comments Off on Histogen to Report Third Quarter 2021 Financial Results on November 10, 2021

SAN DIEGO, Oct. 27, 2021 (GLOBE NEWSWIRE) — Histogen Inc. (NASDAQ: HSTO), a clinical-stage therapeutics company focused on developing potential first-in-class restorative therapeutics that ignite the body’s natural process to repair and maintain healthy biological function, today announced that Histogen’s financial results for the third quarter will be released after… Click here to view original post… […]